Ildong Holdings Co., Ltd. (KRX:000230)
South Korea
· Delayed Price · Currency is KRW 6,080.00
-110.00 (-1.78%)
At close: Apr 16, 2025, 3:30 PM KST
Ildong Holdings Revenue
In the year 2024, Ildong Holdings had annual revenue of 657.57B KRW with 2.99% growth. Ildong Holdings had revenue of 166.34B in the quarter ending December 31, 2024, with 4.89% growth.
Revenue
657.57B
Revenue Growth
+2.99%
P/S Ratio
0.10
Revenue / Employee
8.22B
Employees
80
Market Cap
68.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 657.57B | 19.12B | 2.99% |
| Dec 31, 2023 | 638.45B | -37.09B | -5.49% |
| Dec 31, 2022 | 675.54B | 83.17B | 14.04% |
| Dec 31, 2021 | 592.37B | -4.09B | -0.69% |
| Dec 31, 2020 | 596.47B | 304.25B | 104.12% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 68.13B |
| LigaChem Biosciences | 125.90B |
| PharmaResearch | 350.12B |